Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77

Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q2 EPS of ($1.77).Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.

You May Also Be Interested In

• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Boeing wins $13.4 billion contract modification from US military
• 37 Capital raises $300,000 in partial private placement closing